Year-over-year earnings per share growth for the last twelve months: Tango Therapeutics (TNGX)

tangotx.com (TNGX) - corporate logo

Tango Therapeutics (TNGX) is developing synthetic lethality to combat tumor resistance. The quarterly earnings per share trend on the GURU.Markets terminal chart clearly illustrates financial volatility, where -375.30 captures the current indicator value. Strategic alliances with biopharma behemoths accelerate target discovery, while outsourcing research to external CRO networks optimizes costs and minimizes operational risks.

Tango Therapeutics Inc (TNGX) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for tangotx.com (TNGX)

Comprehensive company analysis:Tango Therapeutics Inc, TNGX
Manufactured product of Tango Therapeutics

The success of Tango Therapeutics (TNGX) depends on the clinical efficacy of its molecules in the fight against cancer. The quarterly EPS change measures the dynamics of net profit per share, reflecting the actual profitability of the business. Growth in this indicator confirms the commercialization of patents, smoothing out speculative price fluctuations. Peak values on the chart signal that the asset is overbought. A stable trend in this metric confirms the fundamental stability of the company.

Competitors of Tango Therapeutics

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Iovance IOVA|Immatics NV - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Xencor Inc. XNCR|CMPX - Year-over-year earnings per share growth for the last twelve months|REPL (replimune.com) - Year-over-year earnings per share growth for the last 12 months|Lyell Pharma (LYEL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Innate Pharma, S.A. (IPHA)|Year-over-year net earnings per share growth for the last 12 months PYXS|CGEN - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months IOBT (IO Biotech Corp)|Year-over-year earnings per share growth rate for the last twelve months STRO|Quarterly EPS earnings growth INKT (MiNK Therapeutics)|Year-over-year earnings per one share growth for the last 12 months HOWL|Immix - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ALX Oncology Holdings Inc.|CUE: Quarterly EPS earnings growth|PDS Biotech - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIA Biotech|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Inc - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP